MARKETS

Company Info

INCOME STATEMENTS

Aarey Drugs & Pharmaceuticals Ltd.

You can view the income statements for the last 5 years.

BSE

May 06

53.99 +1.29 (+ 2.45%)

Volume 7561

Prev. Close 52.70

Open Price 52.40

Today's Low / High

52.00

54.31

Bid Price(Qty.) 0.00 (0)

Open Pr.(Qty.) 0.00 (0)

52 Wk Low / High

31.30

75.75

NSE

May 06

52.72 -0.51 ( -0.96%)

Volume 83784

Prev. Close 53.23

Open Price 53.23

Today's Low / High

52.05

54.38

Bid Price(Qty.) 0.00 (0)

Open Pr.(Qty.) 0.00 (0)

52 Wk Low / High

31.35

74.80

ISIN No	INE198H01019	Market Cap. ( ₹ in Cr. )	149.48	P/BV	1.12	Book Value ( ₹ )	46.93
BSE Code	524412	52 Week High/Low ( ₹ )	75/31	FV/ML	10/1	P/E(X)	31.93
NSE Code	AAREYDRUGSEQ	Book Closure	30/09/2024	EPS ( ₹ )	1.65	Div Yield (%)	0.00

Standalone

(₹ in Crs.)

Particulars	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00


INCOME
Revenue From Operations [Net]	395.62	418.96	492.68	348.42	300.09
Total Operating Revenues	395.62	418.96	492.68	348.42	300.09

Other Income	6.96	2.73	2.75	7.01	6.69
Total Revenue	402.58	421.69	495.43	355.43	306.78

EXPENSES
Purchase Of Stock-In Trade	387.76	418.98	467.29	339.25	285.93
Changes In Inventories Of FG,WIP And Stock-In Trade	-5.86	-15.14	4.78	-1.46	4.25
Employee Benefit Expenses	0.72	0.81	0.98	0.40	0.40
Finance Costs	4.38	2.87	2.00	2.43	1.79
Depreciation And Amortisation Expenses	1.70	1.57	1.99	0.92	0.89
Other Expenses	8.55	6.58	8.37	5.59	6.28
Total Expenses	397.24	415.68	485.40	347.13	299.54

Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	5.34	6.01	10.03	8.30	7.24

Profit/Loss Before Tax	5.34	6.01	10.03	8.30	7.24

Tax Expenses-Continued Operations
Current Tax	1.32	1.78	2.61	1.66	1.50
Deferred Tax	-0.67	-0.04	-0.11	0.12	-0.05
Tax For Earlier Years	0.00	0.50	0.98	0.00	0.00
Total Tax Expenses	0.66	2.24	3.48	1.79	1.45
Profit/Loss After Tax And Before ExtraOrdinary Items	4.68	3.77	6.54	6.51	5.79

Profit/Loss From Continuing Operations	4.68	3.77	6.54	6.51	5.79

Profit/Loss For The Period	4.68	3.77	6.54	6.51	5.79

OTHER INFORMATION

EARNINGS PER SHARE
Basic EPS (Rs.)	1.67	1.49	2.72	2.79	2.48
Diluted EPS (Rs.)	1.67	1.49	2.72	2.79	2.80

Particulars	Mar 24
Months	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR
FaceValue	10.00

INCOME
Revenue From Operations [Net]	395.62
Total Operating Revenues	395.62
Other Income	6.96
Total Revenue	402.58
EXPENSES
Purchase Of Stock-In Trade	387.76
Changes In Inventories Of FG,WIP And Stock-In Trade	-5.86
Employee Benefit Expenses	0.72
Finance Costs	4.38
Depreciation And Amortisation Expenses	1.70
Other Expenses	8.55
Total Expenses	397.24
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	5.34
Profit/Loss Before Tax	5.34
Tax Expenses-Continued Operations
Current Tax	1.32
Deferred Tax	-0.67
Tax For Earlier Years	0.00
Total Tax Expenses	0.66
Profit/Loss After Tax And Before ExtraOrdinary Items	4.68
Profit/Loss From Continuing Operations	4.68
Profit/Loss For The Period	4.68
OTHER INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	1.67
Diluted EPS (Rs.)	1.67